Frequently Asked Questions
The most-asked questions about diseases named after discoverers.
What exactly are 'diseases named after discoverers'?
These are medical conditions that carry the surname or name of the person who first described, identified, or characterized them. The practice is called eponymy, and it spans from widely known conditions like Alzheimer's disease to rarer ones like Prader-Willi syndrome.
Who are the most prominent figures behind these disease names?
Names like Alzheimer, Parkinson, Huntington, and Down appear in everyday medical language, while others like Guillain, Barré, and Turner are recognized mainly by specialists. Most of these individuals were 19th- and early-20th-century physicians, pathologists, or geneticists.
Where should a newcomer begin exploring this topic?
A solid starting point is a general medical dictionary or the International Classification of Diseases, which lists eponymous terms alongside their modern descriptive equivalents. From there, biographical sketches of the original describers add useful historical context.
How many diseases are actually named after people?
Estimates vary, but several thousand medical conditions carry a person's name, ranging from syndromes and tumors to genetic disorders and infections. The exact count shifts as new conditions are described and older eponyms are retired in favor of descriptive terminology.
What are some of the most widely recognized examples?
Alzheimer's disease, Parkinson's disease, and Down syndrome are among the most frequently cited in both clinical and public settings. Others like Guillain-Barré syndrome, Turner syndrome, and Huntington's disease are also well known in medical contexts.
How does a disease actually get named after a person?
Traditionally, a researcher who first clearly describes a condition in a peer-reviewed publication may have their name attached, though the process is informal and not governed by a single authority. In modern practice, many institutions prefer descriptive or mechanistic names over eponyms.
Are there ethical controversies surrounding eponymous disease names?
Yes—several names have been called into question when the original describer had documented ethical violations, such as John Langdon Down, whose theories were rooted in discredited eugenic ideas. Medical societies have debated whether to retire such names while preserving the clinical utility of the term.
What's the difference between an eponymous disease and a descriptively named one?
An eponymous name credits a person (e.g., 'Alzheimer's disease'), whereas a descriptive name explains the mechanism or location (e.g., 'amyotrophic lateral sclerosis' versus 'Lou Gehrig's disease'). Modern nomenclature trends favor the descriptive form for precision, though both often coexist in usage.
Are diseases named after women common?
They exist but are far fewer than male-named conditions, reflecting the historical gender imbalance in medicine. Examples include Turner syndrome, Rett syndrome, and Barth syndrome, though some of these are named after the physician who described them rather than a patient.
What are some notable moments in the history of eponymous naming?
Alois Alzheimer's 1906 description of a plaque-laden brain became a landmark in neuropathology, and the rapid global adoption of terms during the early HIV/AIDS era showed how quickly new eponyms can spread. More recently, WHO guidance encouraging descriptive over eponymous names for newly identified conditions has signaled a broader institutional shift.